In Vitro Diagnostics Market Research Reports & Industry Analysis
In Vitro Diagnostics Industry Research & Market Reports
-
Fertility Testing
... at a CAGR of 6.3% over the analysis period 2023-2030. Ovulation Predictor Kits, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$571.1 Million by the end ... Read More
-
Sepsis Diagnostics
... at a CAGR of 7.5% over the analysis period 2023-2030. Microbiology Technology, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$749.8 Million by the end of ... Read More
-
Slide Stainers
... at a CAGR of 9.6% over the analysis period 2023-2030. Slide Stainer Reagents, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$6.4 Billion by the end ... Read More
-
Microfluidics
... of 16.1% over the analysis period 2023-2030. Microfluidics Devices, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$63.5 Billion by the end of the analysis period. ... Read More
-
Service Laboratories
... at a CAGR of 4.4% over the analysis period 2023-2030. The U.S. Market is Estimated at US$29.5 Billion While China is Forecast to Grow at 4.1% CAGR The Service Laboratories market in the U.S. is ... Read More
-
Point-of-Care (POC) Market Report: Trends, Forecast and Competitive Analysis to 2030
... and home-care setting markets. The global point-of-care (POC) market is expected to reach an estimated $70.0 billion by 2030 with a CAGR of 10.3% from 2024 to 2030. The major drivers for this market are ... Read More
-
North America Hepatitis B Infection Market
... the forecast period of 2024 to 2031. North America Hepatitis B Infection Market Segmentation, By Type (Chronic and Acute), By treatment (Vaccine, Antiviral Drugs, Immune Modulator Drugs, and Surgery, By Countries (U.S., Canada and Mexico)- ... Read More
-
North America Point-of-Care (POC) Drug Abuse Testing Market
... of 4.8% in the forecast period of 2024 to 2031. North America Point-of-Care (POC) Drug Abuse Testing Market, By Drug Type (Amphetamines, Opiates, Cannabinoids, Cocaine, Barbiturates, Benzodiazepines, Methadone, Phencyclidine, Tricyclic Antidepressants, and Others), Products (Devices ... Read More
-
Asia Pacific Hepatitis B Infection Market
... forecast period of 2024 to 2031. Asia-Pacific Hepatitis B Infection Market Segmentation, By Type (Chronic and Acute), By treatment (Vaccine, Antiviral Drugs, Immune Modulator Drugs, and Surgery, By Countries (China, India, Japan, South Korea, Singapore, ... Read More
-
Europe Hepatitis B Infection Market
... period of 2024 to 2031. Europe Hepatitis B Infection Market Segmentation, By Type (Chronic and Acute), By treatment (Vaccine, Antiviral Drugs, Immune Modulator Drugs, and Surgery, By Countries (Germany, U.K., France, Italy, Spain, Russia, Netherlands, ... Read More
-
Enteric Disease Testing
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Bacterial Enteric Disease Testing, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.8 ... Read More
-
Blood Transfusion Devices
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Pathogen Reduction System, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.7 Billion ... Read More
-
Cell Proliferation Kits
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Pharma & Biotech Companies End-Use, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach ... Read More
-
Cervical Cancer Diagnostic Testing
... reach US$10.6 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Pap Smear Test, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and ... Read More
-
Mice Model
... at a CAGR of 5.2% over the analysis period 2023-2030. CRISPR / CAS9 Technology, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$976.7 Million by the ... Read More
-
Flow Chemistry
... at a CAGR of 8.9% over the analysis period 2023-2030. Chemicals Application, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$1.1 Billion by the end of ... Read More
-
Asia Pacific Point-of-Care (POC) Drug Abuse Testing Market
... 5.8% in the forecast period of 2024 to 2031. Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market, By Drug Type (Amphetamines, Opiates, Cannabinoids, Cocaine, Barbiturates, Benzodiazepines, Methadone, Phencyclidine, Tricyclic Antidepressants, and Others), Products (Devices and Consumables ... Read More
-
Global Hepatitis B Infection Market
... period of 2024 to 2031. Global Hepatitis B Infection Market Segmentation, By Type (Chronic and Acute), By treatment (Vaccine, Antiviral Drugs, Immune Modulator Drugs, and Surgery, By Countries (U.S., Canada and Mexico, China, India, Japan, ... Read More
-
Global Point-of-Care (POC) Drug Abuse Testing Market
... in the forecast period of 2024 to 2031. Global Point-of-Care (POC) Drug Abuse Testing Market, By Drug Type (Amphetamines, Opiates, Cannabinoids, Cocaine, Barbiturates, Benzodiazepines, Methadone, Phencyclidine, Tricyclic Antidepressants, and Others), Products (Devices and Consumables and ... Read More
-
Middle East and Africa Point-of-Care (POC) Drug Abuse Testing Market
... growing at a CAGR of 3.3% in the forecast period of 2024 to 2031. Middle East and Africa Point-of-Care (POC) Drug Abuse Testing Market, By Drug Type (Amphetamines, Opiates, Cannabinoids, Cocaine, Barbiturates, Benzodiazepines, Methadone, Phencyclidine, ... Read More
-
Fertility Services
... at a CAGR of 14.9% over the analysis period 2023-2030. Fresh Non-Donor Services, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$75.3 Billion by the end ... Read More
-
Women`s Health Diagnostics
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Breast Cancer Testing Application, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$11.3 ... Read More
-
Cancer Diagnostics
... at a CAGR of 5.7% over the analysis period 2023-2030. Breast Application, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$56.4 Billion by the end of ... Read More
-
Carrier Screening
... at a CAGR of 15.7% over the analysis period 2023-2030. Genetic Disorders, one of the segments analyzed in the report, is expected to record a 18.8% CAGR and reach US$3.0 Billion by the end of ... Read More
-
Cell Isolation / Cell Separation
... is expected to reach US$42.8 Billion by 2030, growing at a CAGR of 16.7% over the analysis period 2023-2030. Consumables Component, one of the segments analyzed in the report, is expected to record a 19.5% ... Read More
Research Assistance
